Novavax (NVAX) Other Working Capital Changes (2010 - 2026)

Novavax's Other Working Capital Changes history runs 6 years deep, the most recent figure standing at $10.3 million for Q4 2018.

• On a quarterly basis, Other Working Capital Changes rose 2189.29% year-over-year to $10.3 million in Q4 2018; TTM through Sep 2018 was -$9.8 million, a 384.45% decrease from a year earlier, with the FY2017 full-year figure at $1.9 million, down 1.53% from the prior year.
• Other Working Capital Changes advanced to $10.3 million in Q4 2018 per NVAX's latest filing, from -$10.3 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $698.9 million in Q2 2025 and bottomed at -$604.0 million in Q1 2025.
• The 5-year median for Other Working Capital Changes is -$51.0 million (2026), against an average of -$34.2 million.
• Across the five-year window, Other Working Capital Changes slumped 87.93% in 2017 and surged 2189.29% in 2018, its largest moves.
• Year by year, Other Working Capital Changes stood at $2.8 million in 2015, then decreased by 29.69% to $2.0 million in 2016, then slumped by 77.18% to $448000.0 in 2017, then jumped by 2189.29% to $10.3 million in 2018.
• Per Business Quant, the three latest NVAX Other Working Capital Changes figures stand at $10.3 million (Q4 2018), -$10.3 million (Q3 2018), and $448000.0 (Q4 2017).